77 related articles for article (PubMed ID: 26993753)
21. Copolymer of poly(ethylene glycol) and poly(L-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery.
Li J; Cheng D; Yin T; Chen W; Lin Y; Chen J; Li R; Shuai X
Nanoscale; 2014; 6(3):1732-40. PubMed ID: 24346086
[TBL] [Abstract][Full Text] [Related]
22. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
[TBL] [Abstract][Full Text] [Related]
23. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
[TBL] [Abstract][Full Text] [Related]
24. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo.
Luo Z; Wang C; Yi H; Li P; Pan H; Liu L; Cai L; Ma Y
Biomaterials; 2015 Jan; 38():50-60. PubMed ID: 25457983
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
26. Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1.
Ishii H; Takada K; Higuchi T; Sugiyama J
Thromb Haemost; 2000 Oct; 84(4):712-21. PubMed ID: 11057875
[TBL] [Abstract][Full Text] [Related]
27. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
[TBL] [Abstract][Full Text] [Related]
28. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
29. Multifaceted targeting of cationic liposomes via co-delivery of anti-IL-17 siRNA and corticosteroid for topical treatment of psoriasis.
Yadav K; Singh D; Singh MR; Pradhan M
Med Hypotheses; 2020 Dec; 145():110322. PubMed ID: 33086162
[TBL] [Abstract][Full Text] [Related]
30. Cg-Rel, the first Rel/NF-kappaB homolog characterized in a mollusk, the Pacific oyster Crassostrea gigas.
Montagnani C; Kappler C; Reichhart JM; Escoubas JM
FEBS Lett; 2004 Mar; 561(1-3):75-82. PubMed ID: 15013754
[TBL] [Abstract][Full Text] [Related]
31. Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease.
Liou HC; Hsia CY
Bioessays; 2003 Aug; 25(8):767-80. PubMed ID: 12879447
[TBL] [Abstract][Full Text] [Related]
32. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery.
Matsumoto S; Christie RJ; Nishiyama N; Miyata K; Ishii A; Oba M; Koyama H; Yamasaki Y; Kataoka K
Biomacromolecules; 2009 Jan; 10(1):119-27. PubMed ID: 19061333
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40.
Xu N; Meisgen F; Butler LM; Han G; Wang XJ; Söderberg-Nauclér C; Ståhle M; Pivarcsi A; Sonkoly E
J Immunol; 2013 Jan; 190(2):678-88. PubMed ID: 23233723
[TBL] [Abstract][Full Text] [Related]
34. The c-Rel subunit of NF-κB is a crucial regulator of phenotype and motility of HaCaT keratinocytes.
Lorenz VN; Schön MP; Seitz CS
Arch Dermatol Res; 2015 Aug; 307(6):523-30. PubMed ID: 25842167
[TBL] [Abstract][Full Text] [Related]
35. NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation.
Donovan CE; Mark DA; He HZ; Liou HC; Kobzik L; Wang Y; De Sanctis GT; Perkins DL; Finn PW
J Immunol; 1999 Dec; 163(12):6827-33. PubMed ID: 10586083
[TBL] [Abstract][Full Text] [Related]
36. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival.
Feng B; Cheng S; Hsia CY; King LB; Monroe JG; Liou HC
Cell Immunol; 2004; 232(1-2):9-20. PubMed ID: 15922711
[TBL] [Abstract][Full Text] [Related]
37. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
38. c-Rel-dependent priming of naive T cells by inflammatory cytokines.
Banerjee D; Liou HC; Sen R
Immunity; 2005 Oct; 23(4):445-58. PubMed ID: 16226509
[TBL] [Abstract][Full Text] [Related]
39. Treatment of psoriasis with NFKBIZ siRNA using topical ionic liquid formulations.
Mandal A; Kumbhojkar N; Reilly C; Dharamdasani V; Ukidve A; Ingber DE; Mitragotri S
Sci Adv; 2020 Jul; 6(30):eabb6049. PubMed ID: 32832675
[TBL] [Abstract][Full Text] [Related]
40. Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinician.
Ali FR; Warren RB
Expert Rev Clin Immunol; 2013 Feb; 9(2):99-101. PubMed ID: 23390938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
